Stock Under $10 with 50-100% upside potential - 14 Days FREE!

US Telelaparoscopy Opportunity Analysis

NEW YORK, Jan. 28, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Telelaparoscopy Opportunity Analysis

http://www.reportlinker.com/p01087851/US-Telelaparoscopy-Opportunity-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

The American Telemedicine Association defines Telemedicine as the use of medical information exchanged from one site to another through electronic communication to improve patients' health status. Globally, the Telemedicine Industry has evolved greatly in recent years from a small niche of healthcare to a full-fledged industry geared up to revolutionize the way healthcare will be administered. In this light, RNCOS has released its new expert analysis on the Telemedicine Industry to reveal its hidden opportunities.

Our extensive research and analysis have led us to identify three areas, where unlimited opportunities lie. Amongst these, "US Telelaparoscopy Opportunity Analysis", provides insights on the Telelaparoscopy general surgery. Presented in 25 slides, this report unfolds the tremendous scope of Telelaparoscopy - an area that RNCOS believes will show robust growth in the future.

The report boasts of a hidden multi-billion dollar market potential for Telelaparoscopy, which if correctly tapped by telemedicine players could be a game changer in not just US but the Global Telemedicine Industry as well. Our report has identified healthcare disparity and uneven burden on general laparoscopic surgeons in the US. To address this, it provides a gap analysis for laparoscopic general surgeons and elucidates how this can be bridged using the extremely sophisticated technique of robot assisted telelaparoscopy surgery. State-wise analysis identifies high risk states that could face shortage of skilled surgeons in the future and provides effective strategies on how this shortage may be combated.

Further, it provides implementable suggestions to telemedicine hardware, software, and network vendors to encash the immense opportunity and prepare for Telelaparoscopy. It presents in a chronological manner the current and future market estimates for the US and Global Telemedicine Industry along with the key segmentation. It also elucidates the drivers and restraints of the US Telemedicine Industry providing insights on what can be expected in the future. From healthcare consultants to existing players, hospital chains to independent physicians and also governments; this report is a must read for all.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,387.58 52.30 0.34%
NASDAQ 3,502.12 5.69 0.16%
S&P 500 1,669.16 2.87 0.17%
US 10 Yr 1.944% -0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs